Nicole R. LeBoeuf

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

Igor Puzanov, Adi Diab, K. Abdallah et al. · Journal for ImmunoTherapy of Cancer · 2017 · 2K citations · Full text

Life Sciences, Immunology, Oncology +17

Ipilimumab for Patients with Relapse after Allogeneic Transplantation

Matthew S. Davids, Haesook T. Kim, Pavan Bachireddy et al. · New England Journal of Medicine · 2016 · 594 citations · Full text

Medicine, Immunology, Oncology +15

<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids

Russell W. Jenkins, Amir Reza Aref, Patrick H. Lizotte et al. · Cancer Discovery · 2017 · 585 citations

Medicine, Immunology, Oncology +17

Skin Effector Memory T Cells Do Not Recirculate and Provide Immune Protection in Alemtuzumab-Treated CTCL Patients

Rachael A. Clark, Rei Watanabe, Jessica E. Teague et al. · Science Translational Medicine · 2012 · 367 citations

Life Sciences, Immunology, Oncology +16

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

Elizabeth C. Townsend, Mark A. Murakami, Alexandra Christodoulou et al. · Cancer Cell · 2016 · 304 citations · Full text

Medicine, Biomedical Sciences, Drug Discovery +6